Genomics

Improved understanding of the tumor microenvironment and genomics has led to new therapies for gastroesophageal and esophageal cancer, potentially improving patient outcomes. Some of these therapies have already transitioned from research to application.

Institut Pasteur de Dakar has sequenced the first 40 human whole genomes in Senegal using Illumina and Oxford Nanopore Technologies. The institution launched a clinical laboratory and bioinformatics platform for testing early-onset breast cancer predisposition and rare heritable gene changes. A multidisciplinary research program integrating genomics, infectious diseases, and environmental factors aims to address cancer's growing burden in Senegal and Africa.

A breach in the UK Biobank has prompted the field of genomics to rethink open science. The incident raises concerns about data security and sharing. Genomics researchers are reevaluating their approach to open science.

A study published in Nature on April 27, 2026, describes a breakthrough in telomere-to-telomere genome assembly using HERRO-corrected simplex nanopore reads. The method enables highly accurate, long-read sequencing for complete genome reconstruction.

A study published in Nature evaluated 37 approved cancer drugs on 1,610 patients using the Drug Rediscovery Protocol, revealing modest overall efficacy but potential benefits for specific subgroups with targeted biomarker selection. The findings suggest off-label drug use could be valuable when combined with rigorous biomarker criteria.

Genomics research indicates France has been producing wine for over 2,500 years, revealing early winemakers employed sophisticated techniques. The findings challenge previous assumptions about the history of viticulture in the region.